A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy and effect of palifermin on the
incidence of oral mucositis in subjects with multiple myeloma receiving Melphalan followed by
autologous peripheral blood stem cell transplantation. Amendment 01 (April 07) introduced
three cataract assessments to be carried out at Screening, Month 6 and Month 12 in response
to FDA and EMEA follow up measures.